ORI found that Respondent engaged in research misconduct by knowingly and intentionally falsifying and/or fabricating data reported in the following published papers and poster presentation:
• Chemical Communications 53(78):10824-10826, 2017 (hereafter referred to as ''Chem. Comm. 2017'').
• Angewandte Chemie-International Edition 56(38):11466-11470, 2017 (hereafter referred to as ''Angewandte Chemie-International Edition 2017'').
• Angewandte Chemie-International Edition 57(5):1342-1345, 2018 (hereafter referred to as ''Angewandte Chemie-International Edition 2018'').
• Polymer macrodiscs for solid-state NMR structural studies on aligned lipid bilayers.'' Presented at the 58th Experimental Nuclear Magnetic Resonance Conference in Pacific Grove (Asilomar), California, March 25-30, 2017 (hereafter referred to as the ''ENMRC Poster 2017'').
ORI found that Respondent intentionally and knowingly falsified and/or fabricated NMR spectroscopy data for structure and dynamics of nanodiscs in thirteen (13) figure panels included in three (3) published papers and one (1) poster presentation by manipulating previously generated NMR data from unrelated experiments to falsely represent NMR spectra for completely different experiments. Specifically, Respondent falsified and/ or fabricated NMR spectra in:
• Chem. Comm. 2017.
- Figure 2A .
- Figure 2B , top and bottom panels.
- Figure 3 , bottom two panels of the right most column.
- Figure S4 , second, third, and the bottom panels from the top.
• Angewandte Chemie-International Edition 2017. (1) Because he also made a false statement in his first admission that no other data were affected in his papers, to exclude himself from any contracting or subcontracting with any agency of the United States Government and from eligibility for or involvement in nonprocurement programs of the United States Government referred to as ''covered transactions'' pursuant to HHS' Implementation (2 CFR part 376) of OMB Guidelines to Agencies on Governmentwide Debarment and Suspension, 2 CFR part 180 (collectively the ''Debarment Regulations''); and (2) to exclude himself from serving in any advisory capacity to PHS including, but not limited to, service on any PHS advisory committee, board, and/or peer review committee, or as a consultant. 
